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Fluctuation of time is de termined by the order and se quence of historical events of global and/or local scale, the harmonization of which reflects the dyna mics of the development of society. The top of universal values of this pro cess was and remains the aca demic science, which is based on the principles of an inextri cable triad: education, science and culture. The intellectual and creative "explosion" of the 20 th and the beginning of the 21 st century has fundamentally changed human consciousness and priority values. Along with the knowledge of physical, natural phenome na and the search for energy sources, man has become not only a subject, but also an object of research. The pace of development of the life sciences reached the apo gee. The struggle for higher expectancy and quality of life is a priority of mo dern science. The key problem of biomedical research has been and remains malig nant neoplasms, which dynamics becomes a threat of civilizational scale.
An important role in actualization of fundamental and applied research in the field of experimental and clinical oncology belongs to the National Academy of Sciences of Ukraine. At the beginning of the 20 th century, the issue of the causes, progression of tumor disease and the search for ways to treat patients was actively debated by scientists and biologists. Expansion of the front of experimental research has greatly accelerated the acquirement of knowledge of the bio logy and morphology of the tumor cell. The undeniable achievement of Ukrainian academic science was the concentration of research on experimental carcinogenesis, initiated by the school of V.V. Pidvysotsky. His disciples were tal ented scholars, including future presidents of the (Kyiv, May 25-30, 1938 ) with an introductory speech "Topi cal Problems of Oncology", he emphasized the need to sys tematize knowledge about ma lignant tumors, further study of etiology, pathogenesis, local and general predisposition to the emergence and development of cancer. Particular empha sis was placed on the need to increase the reactivity of the organism and antitumor immu nity, regardless of the causes of their impairment, which is the basis of prevention and basic principles of treatment of cancer patients. From the standpoint of the pres ent, these theses were the forerunner of strategy of modern therapy. Further intensification of stu dies on nonspecific protective regulatory mechanisms in carcinogenesis showed the role of the factors of the homeostasis system in the formation of anti tumor resistance of the organism at different stages of the development of tumors. World recognition of the priority and achievements of Ukrainian scien tists in the study of the relationship between tumors and the organism was the inclusion in the program of the VIII International Cancer Congress (1962) a separate section meeting devoted to this topic, headed by R.E. Kavetsky, who summarized the re sults of his scientific research in the monographs " Tumour and Host" (1962) and "Interaction of Host and Tumor" (1977) .
In the 1980s, molecular mechanisms of leuke mogenesis, biophysical aspects of blastomogenesis were studied in depth, as well as new models of pre cancerous and tumor processes were developed. The central place in the research was the problem Today, in the structure of the National Academy of Sciences of Ukraine, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radio biology is a powerful center for scientific research on the urgent problems of experimental pathology, biotechno logy and molecular oncology, which made a significant contribution to the treasury of world oncology.
In particular, for the first time, molecular mecha nisms, which determine the peculiarities of the course of chronic lymphocytic leukemia, are dis closed. The role of CD150 and CD180 receptors in the regulation of signaling pathways in malignantly transformed Blymphocytes has been proved. The Institute has prioritized the discovery of a new isoform of CD150 -nCD150 -the sequence of which was submitted to GeneBank (GenBank accession num ber: BankIt1650007 CD150v3 KF471075).
New biomolecular markers of early and differential diagnosis were discovered and certain mechanisms of epithelialmesenchymal transition of cell were determined, probiotic agents and monoclonal anti bodies, which directly influence the key stages of dif ferentiation, transformation and apoptosis of cells, were investigated.
For the first time, the S182 protein, a represen tative of the mitochondrial protein family, has been identified, which is involved in mechanisms for regu lating the uncontrolled proliferation of malignantly transformed cells. The obtained data allow to consider it as one of the potential oncogenes, which opens up prospects for finding out its role in the mechanisms of the tumorhost interactions.
Up to the world standards, studies are being con ducted aimed at a detailed study of lineagespecific and differentiating antigens of cells of hematopoietic and lymphoid tissues of adults and children. In par ticular, it has been shown for the first time that the cellanalogue of acute leukemia, which appears dur ing the progression of myelodysplastic syndromes, irres pective of their primary form, is a leukemic modified stem cell of level 3 (CD117 + , CD33
+ , CD34
-+ , HLADR -+ ), which is normally the progenitor of the myelomonocytic line of hemopoiesis. The obtained data are crucial for the prognosis of the disease, the formation of highrisk groups among patients and the appropriate treatment.
Currently, the study of the role of metalcontaining proteins in the pathogenesis of the most common tumors is actively ongoing.
These and other studies are aimed at early detec tion and timely destruction of cancer cells, taking into account the individual characteristics of the course of tumor disease and maximizing the preservation and rehabilitation of the antitumor resistance system of the organism.
In our time, we received a new understanding of the problem of tumorhost interaction. The view of the tumor as a local process has changed to the perception of the disease of the whole orga nism, which is reflected in the approach to the treatment of cancer patients.
An original technology for the creation of a per sonified treatment -cancer autovaccine, which in cludes biotechnologically modified tumorassociated proteins of autologous tumor material and products of microbial synthesis, is developed. The mechanism of its action is based on the formation of a longterm immune response in a patient that is capable of in hibiting the development of the tumor process due to the ability of the killer cells of the immune system to recognize tumor antigens and thus prevent the development of relapse and metastases. This inno vative development passed a complete cycle of pre clinical and phase III clinical trials. The technological industrial regulations for its production have been elaborated. It took many years before we got the widespread recognition of scientific achievements of the Institute's scientists at the highest level -the 2017 award of the State Prize of Ukraine in the field of Science and Technology "Fundamental Basis of the Realization of Mechanisms of Antitumor Defence of the Organism".
High hopes rely on photodynamic therapy of tu mors -an innovative method for treating patients with malignant neoplasms, which is based on the administration of a special photosensitizer that can ac cumulate primarily in tumor tissue sensitizing it to the following laser irradiation.
In the Institute there have been developed the new types of hemo and enterosorbents, which have unique properties to remove exo and endogenous toxins of different molecular weights, and are used in clinical practice. The newest adsorption band on the basis of activated carbon fibrous materials achieved recognition at the International Festival of Innovative Projects Sikorsky Challenge 2017.
Modern immunocytochemical methods of diag nosing malignant diseases of the hematopoietic and lymphoid tissues have been introduced in accordance with the new WHO classification (2017) using the panel of Ukrainian monoclonal antibodies.
Another important activity of the Institute is the creation of a new generation of nanocomposites for improving the effectiveness of cancer treatment and overcoming resistance to cytostatics, which com bines therapeutic and diagnostic properties in one nanosystem.
Recently, scientific interests are concentrated around the study of miRNAs as an important factor in the epigenetic regulation of gene expression, which allows predicting the course of the oncological process with high accuracy.
In particular, the unique technologies of early diag nosis of cancer (OncoCheckup) and prognosis of the sensitivity to medical treatment (OncoDrugtest) have been developed. The developed technologies are based on the identification of certain panels of selec tive tissuespecific epigenetic oncomarkers (circulat ing miRNAs). The introduction of OncoCheckup and OncoDrugtest in a wide clinical practice allows not only to carry out population screening of the most widespread malignant neoplasms, but also to develop personalized programs for prevention, diagnostics and therapy of cancer.
Oncology is one of the most important, most complex, multivector and socially important di rection of modern medical and biological science. The successful development of fundamental and applied knowledge may be achieved only due to the concentration of efforts and the fruitful consolidation of many scholars from various fields of science within the National Academy of Sciences of Ukraine.
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